Investing.com - AngioDynamics reported on Thursday first quarter earnings that missed analysts' forecasts and revenue that fell short of expectations.
AngioDynamics announced earnings per share of $-0.06 on revenue of $81.5M. Analysts polled by Investing.com anticipated EPS of $-0.02 on revenue of $82.58M.
AngioDynamics shares are down 21% from the beginning of the year and are trading at $21.55 , down-from-52-week-high.
AngioDynamics follows other major Healthcare sector earnings this month
AngioDynamics's report follows an earnings beat by Merck ADR on Friday, September 9, 2022, who reported EPS of $0.5392 on revenue of $5.69B, compared to forecasts EPS of $0.5165 on revenue of $5.57B.
Carl Zeiss Meditec ADR had beat expectations on Friday, September 9, 2022 with third quarter EPS of $0.7134 on revenue of $486.54M, compared to forecast for EPS of $0.7116 on revenue of $486.31M.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar